Literature DB >> 7542536

Changes in serum granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6) after surgical intervention.

H Toda1, A Murata, N Tanaka, I Ohashi, T Kato, H Hayashida, N Matsuura, M Monden.   

Abstract

To evaluate the physiological role of G-CSF following surgery, we measured the serum levels of immunoreactive IL-6 and G-CSF sequentially in nine patients after major elective thoracoabdominal surgery for esophageal carcinoma. Both G-CSF and IL-6 levels reached their maxima at the first postoperative day and decreased thereafter. There was a significant correlation between serum G-CSF (y) and IL-6 (x) levels (y = 3.273x + 3.991; r = 0.787, n = 78, p < 0.001). In the case that developed aspiration pneumonia and ARDS at the second postoperative day, the measured G-CSF level was less than half the predicted value. The relationship between serum G-CSF and IL-6 levels supports the central role of G-CSF as the host defense response modifier and, thus, low G-CSF levels in the circulation is one reason for the immunodeficient state after major surgery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542536

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  3 in total

1.  Flurbiprofen axetil reduces postoperative sufentanil consumption and enhances postoperative analgesic effects in patients with colorectal cancer surgery.

Authors:  Xue Lin; Ruiqin Zhang; Jingchun Xing; Xiaocui Gao; Pan Chang; Wenzhi Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  No compensatory lung growth after resection in a one-year follow-up cohort of patients with lung cancer.

Authors:  Stéphane Glénet; Claire de Bisschop; Frédéric Delcambre; Rodolphe Thiébaut; François Laurent; Jacques Jougon; Jean-François Velly; Agnès Georges; Hervé Guénard
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Effects of flurbiprofen on CRP, TNF-α, IL-6, and postoperative pain of thoracotomy.

Authors:  Hidir Esme; Recep Kesli; Burhan Apiliogullari; Ferdane Melike Duran; Banu Yoldas
Journal:  Int J Med Sci       Date:  2011-03-10       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.